The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
23 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,058,380 in first-year total cost, median $544,030.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMST-H (55)]12
- Special Emphasis Panel[ZRG1 IMST-K (55)]4
- Special Emphasis Panel[ZRG1 IMST-U (55)]3
- Special Emphasis Panel[ZRG1 IMST-L (55)]2
- Special Emphasis Panel[ZRG1 IMST-M (55)]2
Most frequent institutions
- UNIVERSITY OF CALIFORNIA LOS ANGELES3
- UNIV OF NORTH CAROLINA CHAPEL HILL2
- UNIVERSITY OF NEBRASKA MEDICAL CENTER2
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)1
- BRIGHAM AND WOMEN'S HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors1R01CA247652-01A1 | CHANG, SHA XLIBUTTI, STEVEN K.ZAMBONI, WILLIAM C | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $569,509 | ZRG1 |
| 2021 | TNBC Ligand-displaying Exosomes Using RNA Nanotechnology for Targeted Cytosol Delivery of RNAi without Endosome Entrapment1R01CA257961-01 | BINZEL, DANIEL WSHU, DAN | OHIO STATE UNIVERSITY, OH | $331,269 | ZRG1 |
| 2020 | Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer1R01CA253658-01 | BRADBURY, MICHELLE SOVERHOLTZER, MICHAEL H.WIESNER, ULRICH | SLOAN-KETTERING INST CAN RESEARCH, NY | $658,454 | ZRG1 |
| 2020 | Magnetofluorescent nanoplatform for glioblastoma therapy1R01CA253650-01 | YU, JOHN S | CEDARS-SINAI MEDICAL CENTER, CA | $623,483 | ZRG1 |
| 2020 | Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma1R01CA253651-01 | AGOPIAN, VATCHETSENG, HSIAN-RONGYOU, SUNGYONG | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $605,790 | ZRG1 |
| 2020 | Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer1R01CA253615-01 | CHEN, SHAOCHENFIERING, STEVENSTEINMETZ, NICOLE FRANZISKA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $592,114 | ZRG1 |
| 2020 | Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis1R01CA253627-01 | KARATHANASIS, EFSTATHIOSSCHIEMANN, WILLIAM | CASE WESTERN RESERVE UNIVERSITY, OH | $591,007 | ZRG1 |
| 2020 | HER2-targeting transformable nanotherapeutic platform against HER2+ cancers1R01CA247685-01 | LAM, KIT S | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $573,341 | ZRG1 |
| 2020 | Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy1R01CA247666-01A1 | NEL, ANDRE ELIASZINK, JEFFREY I | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $553,064 | ZRG1 |
| 2020 | Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy1R01CA243001-01A1 | CHEN, PENGYUCHEN, WEIQIANG | NEW YORK UNIVERSITY, NY | $544,131 | ZRG1 |
| 2020 | Targeting Effector Immune cells to Cancer with Chemically Self-Assembled Nanorings (CSANs)1R01CA247681-01 | WAGNER, CARSTON R. | UNIVERSITY OF MINNESOTA, MN | $544,030 | ZRG1 |
| 2020 | The development of novel radiation-sensitizer based on ultra-small carbon dots1R01CA247769-01A1 | LI, ZIBOXIE, JIN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $526,148 | ZRG1 |
| 2020 | Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers1R01CA253655-01 | LIN, WENBINWEICHSELBAUM, RALPH R | UNIVERSITY OF CHICAGO, IL | $517,263 | ZRG1 |
| 2020 | Nanotechnology for targeted therapy and fundamental understanding of therapeutic resistance in triple negative breast cancer1R01CA243023-01A1 | HE, XIAOMINGLU, XIONGBIN | UNIV OF MARYLAND, COLLEGE PARK, MD | $472,539 | ZRG1 |
| 2020 | A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines1R01CA247771-01 | ABRAMS, SCOTT I.LOVELL, JONATHAN F | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $393,352 | ZRG1 |
| 2020 | Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer1R01CA247763-01A1 | RACHAGANI, SATYANARAYANA | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $385,840 | ZRG1 |
| 2020 | The Tumor Microenvironment in Nanoparticle Delivery and Function1R01CA253617-01 | BHUJWALLA, ZAVER M. | JOHNS HOPKINS UNIVERSITY, MD | $374,578 | ZRG1 |
| 2019 | Whitlockite nanoparticle-based immunotherapy for bone metastasis1R01CA236702-01 | JANG, HAE LINSENGUPTA, SHILADITYA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $573,510 | ZRG1 |
| 2019 | Copper-depleting nanotheranostics for treating triple negative breast cancer1R01CA243033-01 | RAO, JIANGHONG | STANFORD UNIVERSITY, CA | $535,635 | ZRG1 |
| 2019 | OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA1R01CA232056-01A1 | COLSON, YOLONDA LGRINSTAFF, MARK W.SHIRIHAI, ORIAN S | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $534,718 | ZRG1 |
| 2019 | NanoOptogenetic immunotherapy for B cell lymphoma1R01CA232017-01A1 | HAN, GANGZHOU, YUBIN | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $474,840 | ZRG1 |
| 2018 | Nanodelivery platform for antibody drugs targeting NHL1R01CA232015-01 | KAMATA, MASAKAZU | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $551,578 | ZRG1 |
| 2018 | Novel approach to attenuate small cell lung cancer growth and metastasis1R01CA218545-01A1 | NASSER, MOHD WASIM | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $532,187 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.